THE CHEMOTHERAPY OF ADVANCED BLADDER-CANCER

被引：4
|
作者：
NEWLING, DWW
STOTER, G
SYLVESTER, R
DEPAUW, M
机构：
[1] ROTTERDAM CANC INST,3077 EA ROTTERDAM,NETHERLANDS
[2] EORTC DATA CTR,B-1000 BRUSSELS,BELGIUM
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1987年 / 20卷
关键词：
D O I：
10.1007/BF00262483
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S39 / S43
页数：5
相关论文
共 50 条
  • [41] NEOADJUVANT CHEMOTHERAPY FOR INVASIVE BLADDER-CANCER
    HERR, HW
    [J]. SEMINARS IN SURGICAL ONCOLOGY, 1989, 5 (04): : 266 - 271
  • [42] COMBINATION CHEMOTHERAPY FOR ADVANCED BLADDER-CANCER WITH ADRIAMYCIN, CYCLOPHOSPHAMIDE, AND 5-FLUOROURACIL
    TASHIRO, K
    MACHIDA, T
    MASUDA, F
    OHISHI, Y
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 11 : S43 - S46
  • [43] M-VAC VERSUS CISCA - CHEMOTHERAPY IN THE TREATMENT OF ADVANCED BLADDER-CANCER
    HEIMBACH, D
    WIRTH, M
    FROHMULLER, H
    [J]. UROLOGIA INTERNATIONALIS, 1992, 48 (02) : 157 - 161
  • [44] INTRAARTERIAL INFUSION CHEMOTHERAPY IN COMBINATION WITH ANGIOTENSIN-II FOR ADVANCED BLADDER-CANCER
    MITSUHATA, N
    SEKI, M
    MATSUMURA, Y
    OHMORI, H
    [J]. JOURNAL OF UROLOGY, 1986, 136 (03): : 580 - 585
  • [45] EVALUATION OF SYSTEMIC CHEMOTHERAPY WITH METHOTREXATE, VINBLASTINE, ADRIAMYCIN, AND CISPLATIN FOR ADVANCED BLADDER-CANCER
    KOTAKE, T
    AKAZA, H
    ISAKA, S
    KAGAWA, S
    KOISO, K
    MACHIDA, T
    MARU, A
    MATSUMURA, Y
    MIYAGAWA, I
    NIIJIMA, T
    OBATA, K
    OHASHI, Y
    OHE, H
    OHI, Y
    OKAJIMA, E
    SAKATA, Y
    SHIMAZAKI, J
    TASHIRO, K
    TOGASHI, M
    UEDA, T
    UYAMA, T
    YOSHIKAWA, K
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 : S85 - S89
  • [46] ANALYSES OF FACTORS AFFECTING THE OUTCOME OF COMBINATION CHEMOTHERAPY IN PATIENTS WITH ADVANCED BLADDER-CANCER
    IGAWA, M
    OHKUCHI, T
    UEDA, M
    USUI, T
    KAWANISHI, M
    [J]. EUROPEAN UROLOGY, 1991, 20 (01) : 12 - 15
  • [47] LEARNING TO INTEGRATE SYSTEMIC CHEMOTHERAPY INTO A TREATMENT PLAN FOR PATIENTS WITH ADVANCED BLADDER-CANCER
    SOLOWAY, MS
    [J]. JOURNAL OF UROLOGY, 1985, 133 (03): : 440 - 441
  • [48] MANAGEMENT OF ADVANCED BLADDER-CANCER IN THE ELDERLY
    RAGHAVAN, D
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 1992, 19 (04) : 797 - 806
  • [49] TISSUE POLYPEPTIDE ANTIGEN FOR MONITORING OF ADVANCED BLADDER-CANCER AFTER MVEC CHEMOTHERAPY
    SCHMIDT, A
    BUB, P
    RUTHER, U
    EISENBERGER, F
    [J]. EUROPEAN UROLOGY, 1992, 21 : 10 - 12
  • [50] ARE THE KNOWN BLADDER-CANCER RISK-FACTORS ASSOCIATED WITH MORE ADVANCED BLADDER-CANCER
    HAYES, RB
    FRIEDELL, GH
    ZAHM, SH
    COLE, P
    [J]. CANCER CAUSES & CONTROL, 1993, 4 (02) : 157 - 162
12345